NM_144965.3:c.596A>T
Variant summary
Our verdict is Benign. Variant got -8 ACMG points: 0P and 8B. BP4_StrongBS2
The NM_144965.3(TTC16):c.596A>T(p.Gln199Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000341 in 1,613,322 control chromosomes in the GnomAD database, including 3 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_144965.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -8 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152078Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000306 AC: 77AN: 251224Hom.: 1 AF XY: 0.000375 AC XY: 51AN XY: 135862
GnomAD4 exome AF: 0.000344 AC: 503AN: 1461128Hom.: 3 Cov.: 35 AF XY: 0.000378 AC XY: 275AN XY: 726864
GnomAD4 genome AF: 0.000309 AC: 47AN: 152194Hom.: 0 Cov.: 32 AF XY: 0.000349 AC XY: 26AN XY: 74422
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.596A>T (p.Q199L) alteration is located in exon 6 (coding exon 6) of the TTC16 gene. This alteration results from a A to T substitution at nucleotide position 596, causing the glutamine (Q) at amino acid position 199 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at